Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 44

1.

Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression.

Aherne ST, Madden SF, Hughes DJ, Pardini B, Naccarati A, Levy M, Vodicka P, Neary P, Dowling P, Clynes M.

BMC Cancer. 2015 Apr 30;15:329. doi: 10.1186/s12885-015-1327-5.

2.

A simplified method to recover urinary vesicles for clinical applications, and sample banking.

Musante L, Tataruch D, Gu D, Benito-Martin A, Calzaferri G, Aherne S, Holthofer H.

Sci Rep. 2014 Dec 23;4:7532. doi: 10.1038/srep07532.

3.

Comparative transcriptomic analysis of cultivated limbal epithelium and donor corneal tissue reveals altered wound healing gene expression.

Gallagher C, Clarke C, Aherne ST, Katikireddy KR, Doolan P, Lynch V, Shaw S, Bobart-Hone A, Murphy C, Clynes M, Power W, O'Sullivan F.

Invest Ophthalmol Vis Sci. 2014 Aug 14;55(9):5795-805. doi: 10.1167/iovs.14-14664.

PMID:
25125605
4.

BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome.

Madden SF, Clarke C, Gaule P, Aherne ST, O'Donovan N, Clynes M, Crown J, Gallagher WM.

Breast Cancer Res. 2013;15(4):R52.

5.

A gene expression profile indicative of early stage HER2 targeted therapy response.

O'Neill F, Madden SF, Clynes M, Crown J, Doolan P, Aherne ST, O'Connor R.

Mol Cancer. 2013 Jul 1;12:69. doi: 10.1186/1476-4598-12-69.

6.

MiR-7 triggers cell cycle arrest at the G1/S transition by targeting multiple genes including Skp2 and Psme3.

Sanchez N, Gallagher M, Lao N, Gallagher C, Clarke C, Doolan P, Aherne S, Blanco A, Meleady P, Clynes M, Barron N.

PLoS One. 2013 Jun 6;8(6):e65671. doi: 10.1371/journal.pone.0065671. Print 2013.

7.

Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis.

Clarke C, Madden SF, Doolan P, Aherne ST, Joyce H, O'Driscoll L, Gallagher WM, Hennessy BT, Moriarty M, Crown J, Kennedy S, Clynes M.

Carcinogenesis. 2013 Oct;34(10):2300-8. doi: 10.1093/carcin/bgt208. Epub 2013 Jun 5.

8.

Transcriptomic analysis of clonal growth rate variation during CHO cell line development.

Doolan P, Clarke C, Kinsella P, Breen L, Meleady P, Leonard M, Zhang L, Clynes M, Aherne ST, Barron N.

J Biotechnol. 2013 Jul 10;166(3):105-13. doi: 10.1016/j.jbiotec.2013.04.014. Epub 2013 May 4.

PMID:
23651948
9.

MRI features of bilateral amyloidosis of breast.

O'Brien J, Aherne S, McCormack O, Jeffers M, McInerney D.

Breast J. 2013 May-Jun;19(3):338-9. doi: 10.1111/tbj.12110. No abstract available.

PMID:
23614366
10.

Integrated miRNA, mRNA and protein expression analysis reveals the role of post-transcriptional regulation in controlling CHO cell growth rate.

Clarke C, Henry M, Doolan P, Kelly S, Aherne S, Sanchez N, Kelly P, Kinsella P, Breen L, Madden SF, Zhang L, Leonard M, Clynes M, Meleady P, Barron N.

BMC Genomics. 2012 Nov 21;13:656. doi: 10.1186/1471-2164-13-656.

11.

Gene expression changes as markers of early lapatinib response in a panel of breast cancer cell lines.

O'Neill F, Madden SF, Aherne ST, Clynes M, Crown J, Doolan P, O'Connor R.

Mol Cancer. 2012 Jun 18;11:41. doi: 10.1186/1476-4598-11-41.

12.

Olfactomedin III expression contributes to anoikis-resistance in clonal variants of a human lung squamous carcinoma cell line.

Keenan J, Joyce H, Aherne S, O'Dea S, Doolan P, Lynch V, Clynes M.

Exp Cell Res. 2012 Mar 10;318(5):593-602. doi: 10.1016/j.yexcr.2012.01.012. Epub 2012 Jan 13.

PMID:
22281030
13.

Carotenoid content of commonly consumed herbs and assessment of their bioaccessibility using an in vitro digestion model.

Daly T, Jiwan MA, O'Brien NM, Aherne SA.

Plant Foods Hum Nutr. 2010 Jun;65(2):164-9. doi: 10.1007/s11130-010-0167-3.

PMID:
20443063
14.

Bioaccessibility, uptake, and transport of carotenoids from peppers (Capsicum spp.) using the coupled in vitro digestion and human intestinal Caco-2 cell model.

O'Sullivan L, Jiwan MA, Daly T, O'Brien NM, Aherne SA.

J Agric Food Chem. 2010 May 12;58(9):5374-9. doi: 10.1021/jf100413m.

PMID:
20329773
15.

Bioactive properties of wood knot extracts on cultured human cells.

Phelan M, Aherne SA, Wong A, O'Brien NM.

J Med Food. 2009 Dec;12(6):1245-51. doi: 10.1089/jmf.2008.0125.

PMID:
20041777
16.

Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patients.

Gallagher MF, Flavin RJ, Elbaruni SA, McInerney JK, Smyth PC, Salley YM, Vencken SF, O'Toole SA, Laios A, Lee MY, Denning K, Li J, Aherne ST, Lao KQ, Martin CM, Sheils OM, O'Leary JJ.

J Ovarian Res. 2009 Dec 16;2:19. doi: 10.1186/1757-2215-2-19.

17.

Geographical location has greater impact on carotenoid content and bioaccessibility from tomatoes than variety.

Aherne SA, Jiwan MA, Daly T, O'Brien NM.

Plant Foods Hum Nutr. 2009 Dec;64(4):250-6. doi: 10.1007/s11130-009-0136-x.

PMID:
19757067
18.

Bioactivity of herb-enriched beef patties.

Ryan E, Aherne SA, O'Grady MN, McGovern L, Kerry JP, O'Brien NM.

J Med Food. 2009 Aug;12(4):893-901. doi: 10.1089/jmf.2008.0069.

PMID:
19735192
19.

miR-29b expression is associated with disease-free survival in patients with ovarian serous carcinoma.

Flavin R, Smyth P, Barrett C, Russell S, Wen H, Wei J, Laios A, O'Toole S, Ring M, Denning K, Li J, Aherne S, Sammarae D, Aziz NA, Alhadi A, Finn SP, Loda M, B S, Sheils O, O'Leary JJ.

Int J Gynecol Cancer. 2009 May;19(4):641-7. doi: 10.1111/IGC.0b013e3181a48cf9.

PMID:
19509563
20.

Prosthodontic rehabilitation of hypophosphatasia using dental implants: a review of the literature and two case reports.

Lynch CD, Ziada HM, Buckley LA, O'Sullivan VR, Aherne T, Aherne S.

J Oral Rehabil. 2009 Jun;36(6):462-8. doi: 10.1111/j.1365-2842.2009.01948.x. Epub 2009 May 5. Review.

PMID:
19422434
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk